3 Recruiting Multiple Sclerosis, Relapsing-Remitting Phase 3 Clinical Trials

Active phase 3 studies for multiple sclerosis, relapsing-remitting enrolling across the USA. Verify eligibility and contact site coordinators.

All Multiple Sclerosis, Relapsing-Remitting studies

Phase 3 Studies for Multiple Sclerosis, Relapsing-Remitting

🔵 Active, Not Recruiting Phase3

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

📍 UC San Diego Health — La Jolla, California

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3

Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

📍 Neuro of Central Florida — Altamonte Springs, Florida

View Study & Checklist ➔

🟢 Recruiting Phase3

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

📍 Local Institution - 0114 — Loma Linda, California

View Study & Checklist ➔